Anzeige
Mehr »
Freitag, 16.05.2025 - Börsentäglich über 12.000 News
Verpasst du gerade die Buffett-Aktie der neuen Generation?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0RC46 | ISIN: US2307701092 | Ticker-Symbol:
NASDAQ
15.05.25 | 21:14
5,230 US-Dollar
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
CUMBERLAND PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
CUMBERLAND PHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur CUMBERLAND PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
09.05.CUMBERLAND PHARMACEUTICALS INC - 10-Q, Quarterly Report1
06.05.CUMBERLAND PHARMACEUTICALS INC - 8-K, Current Report2
06.05.Cumberland Pharmaceuticals Inc.: Cumberland Pharmaceuticals Reports 38% Revenue Growth in Q1 202531NASHVILLE, Tenn., May 6, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that its product...
► Artikel lesen
28.04.CUMBERLAND PHARMACEUTICALS INC - 8-K, Current Report1
CUMBERLAND PHARMACEUTICALS Aktie jetzt für 0€ handeln
19.03.CUMBERLAND PHARMACEUTICALS INC - 8-K, Current Report3
07.03.CUMBERLAND PHARMACEUTICALS INC - 10-K, Annual Report-
04.03.CUMBERLAND PHARMACEUTICALS INC - 8-K, Current Report-
04.03.Cumberland Pharmaceuticals Inc.: Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth1312024 highlights include expanded product labeling, key FDA designations and new study publications Recent developments include Phase 2 DMD Study Breakthrough Results...
► Artikel lesen
14.02.CUMBERLAND PHARMACEUTICALS INC - 8-K, Current Report-
04.02.CUMBERLAND PHARMACEUTICALS INC - 8-K, Current Report-
04.02.Cumberland Pharmaceuticals' Duchenne Candidate Shows Improved Heart Function In Patients With Associated Heart Disease3
04.02.Cumberland Pharmaceuticals Inc.: Cumberland Pharmaceuticals Announces Breakthrough Results from the Phase 2 FIGHT DMD Trial in Duchenne Muscular Dystrophy Heart Disease155NASHVILLE, Tenn., Feb. 4, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company with development efforts focused...
► Artikel lesen
10.12.24Why Is Cumberland Pharmaceuticals Stock Trading Over 100% on Tuesday?6
09.12.24Cumberland Pharmaceuticals Inc.: FDA Approves Acetadote sNDA126- New Dosing Regimen Simplifies Administration - NASHVILLE, Tenn., Dec. 9, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty...
► Artikel lesen
09.12.24CUMBERLAND PHARMACEUTICALS INC - 8-K, Current Report-
07.11.24Cumberland Pharmaceuticals Inc.: Cumberland Pharmaceuticals Reports Third Quarter 2024 Financial Results and Company Update113- New Real World Study of 150,000 Patients Favors Caldolor over ketorolac - - DMD Program Receives FDA Orphan Drug & Rare Pediatric Disease Designations...
► Artikel lesen
06.11.24Cumberland Pharmaceuticals Inc.: Cumberland Pharmaceuticals Receives FDA Orphan Drug And Rare Pediatric Disease Designations For New Treatment Of Duchenne Muscular Dystrophy175NASHVILLE, Tenn., Nov. 6, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that the United...
► Artikel lesen
06.08.24Cumberland Pharmaceuticals Inc.: Cumberland Pharmaceuticals Reports 16% Sequential Revenue Growth in Second Quarter 2024156NASHVILLE, Tenn., Aug. 6, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced significantly improved financial results and a...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1